CIMCX
Price
$26.53
Change
+$0.10 (+0.38%)
Updated
Jul 16 closing price
Net Assets
133.92B
FGGBX
Price
$2.69
Change
-$0.00 (-0.00%)
Updated
Jul 16 closing price
Net Assets
304.93M
Interact to see
Advertisement

CIMCX vs FGGBX

Header iconCIMCX vs FGGBX Comparison
Open Charts CIMCX vs FGGBXBanner chart's image
American Funds Income Fund of Amer 529C
Price$26.53
Change+$0.10 (+0.38%)
VolumeN/A
Net Assets133.92B
Templeton Global Balanced R6
Price$2.69
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets304.93M
CIMCX vs FGGBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CIMCX vs. FGGBX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIMCX is a Buy and FGGBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMCX has more cash in the bank: 134B vs. FGGBX (305M). CIMCX pays higher dividends than FGGBX: CIMCX (2.95) vs FGGBX (2.60). CIMCX was incepted earlier than FGGBX: CIMCX (23 years) vs FGGBX (12 years). CIMCX (1.36) is less costly to investors than FGGBX (0.96). CIMCX is a more actively managed with annual turnover of: 92.00 vs. FGGBX (43.31). CIMCX has a lower initial minimum investment than FGGBX: CIMCX (250) vs FGGBX (1000000). FGGBX (10.72) and CIMCX (10.40) have marching annual gain over last year. CIMCX return over 5 years is better than : 40.10 vs. FGGBX (27.24).
CIMCXFGGBXCIMCX / FGGBX
Total Expense Ratio1.360.89153%
Annual Report Gross Expense Ratio1.360.96142%
Fund Existence23 years12 years-
Gain YTD10.21314.64470%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets134B305M43,934%
Annual Yield % from dividends2.952.60113%
Returns for 1 year10.4010.7297%
Returns for 3 years26.2836.3872%
Returns for 5 years40.1027.24147%
Returns for 10 years58.2013.60428%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RAPP15.220.84
+5.84%
Rapport Therapeutics Inc.
LGND129.635.33
+4.29%
Ligand Pharmaceuticals
GSIW1.690.06
+3.68%
Garden Stage Limited
MIND7.340.19
+2.66%
MIND Technology
VTRS9.080.15
+1.68%
Viatris